These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23742732)
1. A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy. Chavez-Tapia NC; Cesar-Arce A; Barrientos-Gutiérrez T; Villegas-López FA; Méndez-Sanchez N; Uribe M Nutr J; 2013 Jun; 12():74. PubMed ID: 23742732 [TBL] [Abstract][Full Text] [Related]
2. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. Shen YC; Chang YH; Fang CJ; Lin YS Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342 [TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177 [TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410 [TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids for people with hepatic encephalopathy. Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283 [TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Zacharias HD; Zacharias AP; Gluud LL; Morgan MY Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790 [TBL] [Abstract][Full Text] [Related]
7. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL; Vilstrup H; Morgan MY Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247 [TBL] [Abstract][Full Text] [Related]
8. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Gluud LL; Vilstrup H; Morgan MY Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005 [TBL] [Abstract][Full Text] [Related]
10. Nutritional support for liver disease. Koretz RL; Avenell A; Lipman TO Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729 [TBL] [Abstract][Full Text] [Related]
11. Probiotics for people with hepatic encephalopathy. Dalal R; McGee RG; Riordan SM; Webster AC Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008716. PubMed ID: 28230908 [TBL] [Abstract][Full Text] [Related]
12. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Goh ET; Andersen ML; Morgan MY; Gluud LL Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002798. PubMed ID: 28745801 [TBL] [Abstract][Full Text] [Related]
13. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Riggio O; Ariosto F; Merli M; Caschera M; Zullo A; Balducci G; Ziparo V; Pedretti G; Fiaccadori F; Bottari E Dig Dis Sci; 1991 Sep; 36(9):1204-8. PubMed ID: 1893805 [TBL] [Abstract][Full Text] [Related]
14. Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis. Diglio DC; Fernandes SA; Stein J; Azeredo-da-Silva A; de Mattos AA; Tovo CV Ann Hepatol; 2020; 19(2):190-196. PubMed ID: 31611064 [TBL] [Abstract][Full Text] [Related]
16. Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age. Lassi ZS; Kurji J; Oliveira CS; Moin A; Bhutta ZA Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010205. PubMed ID: 32266964 [TBL] [Abstract][Full Text] [Related]